This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_FIBROSARCOMA_EXALLC for full statistics.
Fibrosarcoma
C3_FIBROSARCOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
246 |
4. Check minimum number of eventsNone |
246 |
5. Include endpointsNone |
246 |
6. Filter based on genotype QC (FinnGen only) |
246 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Fibrosarcoma
based on the number of shared cases.
Similar with more cases:
- Fibrosarcoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 246 | 118 | 128 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 50.83 | 49.98 | 51.62 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 230
- Matched controls
- 2300
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8832/3-C44.5
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of trunk
+∞
44.2
41
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
22.2
21
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
17.9
17
*
8832/3-C44.7
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of lower limb and hip
+∞
17.9
17
*
C49.25
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip fibrosarcoma
+∞
17.9
17
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
16.9
16
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
16.9
16
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
+∞
15.8
15
*
8832/3-C44.6
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of upper limb and shoulder
+∞
15.8
15
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
171.2
15.7
16
*
C49.15
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder fibrosarcoma
+∞
14.7
14
*
ZZA00
NOMESCO Finland
Split skin graft
12.0
13.9
25
23
C49.21
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip malignant fibrotic histiocytoma
+∞
13.7
13
*
8830/3-C49.2
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
13.7
13
*
130
Kela drug reimbursment
Malignant tumour
5.0
13.2
44
103
8832/3-C44.9
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin, NOS
+∞
12.6
12
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
12.6
12
*
C49.11
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder malignant fibrotic histiocytoma
+∞
12.6
12
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
14.5
12.2
20
15
ZZR10
NOMESCO Finland
Flap of skin and muscle
31.9
11.8
15
5
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
11.6
11
*
8811/3-C49.2
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
11.6
11
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
11.6
11
*
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
11.6
11
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
10.4
11.0
21
22
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
13.8
10.8
18
14
8830/3-C49.1
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.5
10
*
8830/3-C49.6
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
10.5
10
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.5
10.4
37
93
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
9.4
9
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
+∞
9.4
9
*
8810/3-C49.1
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
9.4
9
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.3
9.4
20
26
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
38.3
9.1
11
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
11.4
8.9
16
15
ZZR00
NOMESCO Finland
Flap of skin
7.9
8.6
19
26
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
8.4
8
*
8810/3-C49.2
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
8.4
8
*
C49.35
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thoracic fibrosarcoma
+∞
8.4
8
*
8811/3-C49.1
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
8.4
8
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.5
7.6
26
63
JN4CD
NOMESCO Finland
Very extensive body CT
5.5
7.5
21
41
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
7.4
61
282
8811/3-C49.5
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of pelvis
+∞
7.3
7
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
7.3
7
*
C49.00
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck without histology
+∞
7.3
7
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
7.0
7.3
17
26
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
7.2
75
394
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
7.4
7.1
16
23
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
17.3
6.8
10
6
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
41.3
6.8
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
6.7
113
727
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
71.8
6.5
7
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
71.8
6.5
7
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
7.4
6.3
14
20
C49.45
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of abdominal fibrosarcoma
+∞
6.3
6
*
C49.1
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder
+∞
6.3
6
*
17131
ICD-8 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb (including hip)
+∞
6.3
6
*
NE1CM
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with 3 Tesla magnet
+∞
6.3
6
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
13.0
6.1
10
8
WF003
NOMESCO Finland
Adjuvant radiotherapy
4.8
6.1
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
9
24
3.85
2.70
1.0
1.1
—
—
—
0
0
136
1125
1.47
2.29
10.8
9.3
3.9
4.2
e9/l
0.83
123
985
68
499
1.50
2.06
2.3
2.4
—
—
—
0
0
114
931
1.42
1.96
3.9
4.1
—
—
—
0
0
7
22
3.24
1.89
1.1
1.7
12.6
17.3
ug/l
—
7
22
8
28
2.92
1.88
1.5
1.4
—
—
—
0
0
175
1552
1.44
1.83
9.0
7.8
81.2
81.1
u/l
0.01
169
1432
12
54
2.28
1.77
1.2
1.3
—
—
—
0
0
6
19
3.21
1.67
1.5
1.3
—
—
—
0
0
36
248
1.53
1.46
5.3
6.9
0.4
1.4
mmol/l
0.74
28
199
109
923
1.32
1.36
5.9
6.2
1.2
1.2
mmol/l
0.02
102
830
125
1082
1.32
1.33
8.2
6.6
13.5
11.4
umol/l
0.42
119
1019
30
423
0.67
1.25
1.9
1.8
1099.5
1254.8
nmol/l
0.39
23
331
8
40
2.03
1.13
1.1
1.4
—
—
—
0
0
10
52
1.96
1.07
1.4
1.3
—
—
—
0
0
10
52
1.96
1.07
1.4
1.3
—
—
—
0
0
10
54
1.89
0.98
1.6
1.4
—
—
—
0
0
9
52
1.76
0.93
1.4
1.3
—
—
—
0
0
113
999
1.24
0.92
6.4
7.1
1.2
1.2
mmol/l
0.57
98
850
23
320
0.69
0.91
1.3
1.3
21.3
35.1
iu/ml
—
5
107
74
860
0.80
0.84
2.9
4.0
23.1
45.8
ng/l
2.71
52
622
35
446
0.75
0.82
1.4
1.7
497.8
472.9
pmol/l
0.12
28
367
157
1450
1.23
0.81
3.6
4.3
10.9
13.1
mm/h
1.54
143
1326
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
10
59
1.72
0.77
1.1
1.2
—
—
—
0
0
6
34
1.78
0.77
1.0
1.1
—
—
—
0
0
7
38
1.87
0.74
1.0
1.5
0.7
0.8
nmol/l
—
7
31
44
357
1.28
0.73
2.7
2.8
0.7
1.1
e6/l
0.79
26
204
10
60
1.69
0.73
1.1
1.2
—
—
—
0
0
66
568
1.22
0.67
2.6
3.2
0.3
0.6
e6/l
0.81
54
424
12
78
1.57
0.67
1.1
1.3
—
—
—
0
0
14
95
1.50
0.65
1.1
1.3
75.0
121.5
iu/ml
—
5
34
34
271
1.30
0.65
4.4
6.5
105.5
103.4
mmol/l
2.74
34
261
173
1822
0.83
0.63
6.3
6.2
39.7
40.7
mmol/mol
1.05
160
1692
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
21
161
1.33
0.54
4.0
4.5
1.2
1.2
mmol/l
0.93
21
142
30
244
1.26
0.51
2.5
3.0
10.9
8.1
umol/l
0.22
24
215
201
1938
1.20
0.49
16.4
16.0
23.9
25.1
mg/l
0.20
160
1565
8
120
0.66
0.47
3.5
1.8
—
—
—
0
0
129
1211
1.14
0.43
4.1
4.8
6.5
6.8
mmol/l
1.51
123
1140
6
93
0.64
0.43
1.3
2.0
—
—
—
0
0
26
213
1.25
0.43
3.6
3.5
—
—
—
0
0
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
8
58
1.39
0.42
1.4
1.3
—
—
—
0
0
15
114
1.34
0.42
1.7
1.8
—
—
—
0
0
24
196
1.25
0.41
2.7
2.1
0.2
0.2
g/l
0.03
24
181
23
187
1.25
0.40
5.7
6.4
1.3
1.3
mmol/l
0.10
23
178
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
5
36
1.40
0.38
1.2
1.7
—
—
—
0
0
28
235
1.22
0.38
5.0
4.3
4.9
28.4
ug/l
0.68
23
189
29
245
1.21
0.37
1.9
1.9
—
—
—
0
0
13
167
0.77
0.35
4.2
3.6
100.8
83.6
ng/l
0.38
13
152
10
73
1.39
0.35
2.3
3.0
—
—
—
0
0
14
177
0.78
0.34
2.8
1.9
283.1
395.2
nmol/l
1.59
14
161
29
248
1.19
0.33
2.0
2.0
—
—
—
0
0
17
137
1.26
0.33
2.5
1.8
—
—
—
0
0
13
102
1.29
0.30
1.1
1.2
333.6
148.0
u/ml
0.58
13
92
18
148
1.23
0.30
1.3
1.6
—
—
—
0
0
7
55
1.28
0.30
1.0
1.4
—
—
—
0
0
8
106
0.75
0.29
3.4
1.7
—
—
—
0
0
38
337
1.15
0.29
2.7
2.9
1.3
1.8
e6/l
0.20
19
186
13
104
1.26
0.27
3.6
3.5
4.6
4.8
pmol/l
0.40
13
90
30
264
1.16
0.26
8.5
8.0
—
—
—
0
0
38
343
1.13
0.24
1.8
1.9
—
—
—
0
0
35
388
0.89
0.23
1.3
1.2
0.5
1.1
u/ml
—
6
119
28
248
1.15
0.23
5.9
4.9
32.6
31.9
%
0.14
19
156
190
1940
0.91
0.22
4.8
5.2
2.8
2.7
mmol/l
0.45
171
1779
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
3.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
8.8
—
0
11
0
11
0.00
0.21
0.0
3.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
24.1
—
0
12
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
0
12
0.00
0.21
0.0
4.3
—
225.0
—
0
12
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
0.9
—
0
7
6
50
1.20
0.20
1.2
1.8
—
—
—
0
0
6
51
1.18
0.19
1.2
1.8
—
—
—
0
0
37
403
0.90
0.19
2.9
4.0
32.8
258.5
ng/l
1.81
29
324
16
138
1.17
0.18
1.8
1.4
—
—
—
0
0
83
792
1.07
0.17
2.7
2.6
190.5
130.2
ug/l
0.87
75
721
19
168
1.14
0.16
3.8
2.9
61.4
61.0
ml/min/173m2
—
8
71
93
967
0.94
0.16
3.5
4.0
0.0
0.0
estimate
0.50
19
164
22
197
1.13
0.16
1.1
1.4
—
—
—
0
0
6
77
0.77
0.16
1.2
1.8
—
—
—
0
0
9
80
1.13
0.15
1.0
1.0
—
—
—
0
0
92
955
0.94
0.15
4.3
5.3
0.0
0.0
estimate
0.00
20
168
58
610
0.94
0.14
3.4
4.3
22.0
21.6
%
0.07
31
289
48
508
0.93
0.13
1.4
1.5
24.9
20.4
nmol/l
0.74
43
422
48
506
0.94
0.12
2.1
2.0
3.1
3.0
mg/l
0.08
41
451
187
1896
0.94
0.12
4.5
4.7
4.7
4.6
mmol/l
0.33
170
1753
186
1885
0.95
0.11
4.4
4.7
1.4
1.5
mmol/l
1.35
169
1726
45
429
1.06
0.09
1.9
1.7
0.9
1.2
mg/l
0.66
35
332
5
47
1.07
0.09
1.0
1.2
—
—
—
0
0
77
794
0.96
0.09
2.3
2.3
77.2
77.1
nmol/l
0.01
71
691
6
56
1.07
0.08
1.3
1.7
—
—
—
0
0
5
63
0.79
0.08
7.4
3.8
—
3.8
—
0
6
5
64
0.78
0.08
7.8
3.8
27.5
31.4
mg/l
—
5
52
5
64
0.78
0.08
7.8
3.8
39.9
173.1
mg/l
—
5
53
207
2052
1.06
0.08
12.4
11.0
27.7
25.8
u/l
0.72
198
1976
185
1831
1.04
0.07
17.1
14.6
80.2
77.8
ml/min/173m2
0.89
161
1507
85
830
1.04
0.07
1.8
2.1
104.4
93.3
pmol/l
1.34
50
416
78
761
1.04
0.07
4.6
5.0
2.6
2.6
ug/l
0.00
68
668
73
748
0.97
0.06
3.9
4.2
—
—
—
0
0
53
515
1.04
0.05
4.5
4.4
0.0
0.0
estimate
0.00
20
161
181
1825
0.97
0.05
3.9
4.2
1.4
1.3
mmol/l
1.33
165
1668
94
955
0.97
0.04
3.4
3.9
0.0
0.0
estimate
0.00
21
168
146
1445
1.03
0.04
3.5
3.9
14.9
15.0
pmol/l
0.11
132
1284
28
270
1.04
0.03
1.3
1.3
—
—
—
0
0
75
738
1.02
0.03
2.9
3.3
—
—
—
0
0
169
1702
0.98
0.03
18.1
16.8
40.4
39.4
%
0.84
114
1188
187
1881
0.98
0.03
4.6
4.9
6.0
6.1
mmol/l
0.67
170
1713
110
1089
1.02
0.02
2.5
2.7
—
—
—
0
0
63
639
0.98
0.02
2.4
2.6
55.4
54.9
u/l
0.03
58
585
68
674
1.01
0.00
5.7
3.5
2.4
2.4
mmol/l
0.18
59
581
30
301
1.00
0.00
1.3
1.3
1.1
4.5
u/ml
1.70
11
116
174
1744
0.99
0.00
4.3
4.7
1.9
1.9
mu/l
0.24
159
1566
127
1266
1.01
0.00
3.1
3.3
44.6
51.9
u/l
0.73
120
1170
51
507
1.01
0.00
1.6
1.6
1.4
1.3
mmol/l
0.23
44
419
44
442
0.99
0.00
2.6
3.0
0.6
0.8
ug/l
1.48
31
286
5
49
1.02
0.00
1.0
1.2
—
20.0
—
0
5
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
54
0.92
0.00
2.2
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
6
63
0.95
0.00
1.2
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_FIBROSARCOMA – Fibrosarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).